What Is a Peptide Certificate of Analysis
A Certificate of Analysis (COA) is a formal document issued by an analytical laboratory that verifies the identity, purity, and quality of a specific production batch. For research peptides, the COA serves as the primary documentation confirming that the material meets established specifications before release for laboratory use.
Each certificate is batch-specific, meaning it applies only to the exact lot number referenced on the document. This traceability ensures that researchers can verify the quality parameters of the specific material in their possession, not a generalized product claim. The COA typically includes the product name, batch/lot number, manufacturing date, analysis date, testing laboratory identification, and detailed results for each analytical method performed.
Legitimate peptide COA documentation distinguishes research-grade suppliers from those making unverified claims. Without batch-specific analytical data, there is no way to confirm that a peptide meets the stated purity or even contains the correct amino acid sequence.
Understanding HPLC Purity Testing
High-Performance Liquid Chromatography (HPLC) is the gold standard analytical method for determining peptide purity. This technique separates mixture components based on their differential interactions with a stationary phase and mobile solvent, producing a chromatogram that reveals both the target peptide peak and any impurities present in the sample.
Purity percentage is calculated by comparing the area of the main peptide peak to the total area of all detected peaks. A specification of ≥99% purity indicates that at least 99% of the detected material consists of the target peptide sequence, with less than 1% comprising synthesis-related impurities, deletion sequences, or degradation products.
HPLC testing for BPC-157, Semaglutide, and other research peptides typically employs reversed-phase columns with gradient elution methods optimized for peptide separation. The resulting chromatogram provides visual confirmation of purity that researchers can directly evaluate.
Mass Spectrometry Confirmation
Mass spectrometry (MS) provides definitive confirmation of peptide identity by measuring the molecular weight of the compound. This technique ionizes the peptide molecules and separates them based on their mass-to-charge ratio, producing a spectrum that can be compared against the theoretical molecular weight calculated from the amino acid sequence.
For peptide verification, electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization (MALDI) are commonly employed. The observed mass must match the expected value within instrumental tolerance—typically ±0.1% for ESI-MS—to confirm that the synthesized peptide contains the correct sequence.
Mass spectrometry is essential because HPLC purity alone cannot confirm identity. A sample could show high chromatographic purity but contain the wrong peptide entirely. MS analysis eliminates this uncertainty by providing molecular weight confirmation that supplements the purity data. Products like Tirzepatide and Retatrutide with complex structures particularly benefit from MS verification.
Batch Numbers and Traceability
Every legitimate Certificate of Analysis references a unique batch or lot number that identifies the specific production run. This alphanumeric identifier links the analytical documentation to the exact material produced, enabling full traceability from synthesis through testing to final distribution.
Batch traceability serves multiple purposes in research contexts. It allows researchers to correlate experimental results with specific material lots, facilitating reproducibility and troubleshooting. If quality concerns arise, batch numbers enable rapid identification of affected inventory and documentation review.
When verifying a COA, the batch number on the certificate must match the batch number printed on the product vial or packaging. Any discrepancy indicates either documentation error or potential substitution, and researchers should request clarification before using the material.
Third-Party Laboratory Verification
Independent third-party testing provides an additional layer of quality assurance beyond in-house analytical results. Third-party laboratories operate independently from the peptide supplier, eliminating potential conflicts of interest and providing unbiased verification of quality claims.
Accredited testing facilities such as Janoshik Analytical specialize in peptide verification for the research market. These laboratories maintain ISO 17025 accreditation or equivalent quality management systems, ensuring standardized testing protocols and documented traceability.
COAs marked as "Janoshik Verified" on this page indicate batches that have undergone independent analytical confirmation in addition to manufacturing QC testing. This dual verification approach provides researchers with enhanced confidence in the documented quality parameters.
How to Verify a COA
Verifying the authenticity and accuracy of a Certificate of Analysis requires systematic evaluation of several elements. First, confirm that the batch number on the certificate matches the batch number on your product packaging exactly. Any mismatch invalidates the documentation for your specific material.
Review the analysis date relative to your purchase. COAs should reference recent testing appropriate to the shelf life of the material. Examine the testing laboratory identification—legitimate certificates specify the testing facility, while vague or absent laboratory information raises concerns.
For enhanced verification, cross-reference third-party tested batches directly with the testing laboratory when verification URLs are provided. Janoshik and similar services maintain searchable databases of their issued certificates, allowing independent confirmation that the documentation is genuine.
Why Batch Transparency Matters in Research
Batch-specific documentation is fundamental to research integrity and reproducibility. When experimental protocols reference specific peptide lots with verified quality parameters, other researchers can obtain equivalent materials to replicate findings. Without this traceability, variations in peptide quality become confounding variables.
For peptides used in sensitive research applications—such as CJC-1295 DAC in growth hormone studies or Ipamorelin in secretagogue research—batch documentation enables researchers to evaluate whether observed results correlate with material quality or other experimental factors.
Transparent batch documentation also supports compliance with institutional requirements. Many research facilities require analytical documentation for materials used in funded projects. Comprehensive COAs satisfy these requirements while demonstrating due diligence in material sourcing. For additional quality documentation standards, see our Documentation & Quality Standards page.
